Barclays PLC Vericel Corp Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Vericel Corp stock. As of the latest transaction made, Barclays PLC holds 110,046 shares of VCEL stock, worth $5.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,046

Previous 111,527 1.33%

Holding current value

$5.22 Million

Previous $4.71 Million 28.25%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$40.05 - $59.11 $59,314 - $87,541	-1,481 Reduced 1.33%	110,046 $6.04 Million
Q3 2024 Nov 15, 2024	BUY	$42.25 - $53.56 $2.79 Million - $3.54 Million	66,082 Added 145.41%	111,527 $4.71 Million
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $740,269 - $938,869	-17,748 Reduced 28.09%	45,445 $2.09 Million
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $2.06 Million - $3.32 Million	-63,417 Reduced 50.09%	63,193 $3.29 Million
Q4 2023 Feb 15, 2024	BUY	$30.85 - $37.09 $3.9 Million - $4.69 Million	126,398 Added 59621.7%	126,610 $4.51 Million
Q3 2023 Nov 07, 2023	SELL	$31.69 - $39.25 $843,207 - $1.04 Million	-26,608 Reduced 99.21%	212 $8,000
Q2 2023 Aug 03, 2023	BUY	$29.0 - $38.37 $776,040 - $1.03 Million	26,760 Added 44600.0%	26,820 $1.01 Million
Q1 2023 May 04, 2023	BUY	$23.85 - $31.34 $1,431 - $1,880	60 New	60 $2,000
Q3 2022 Nov 03, 2022	BUY	$22.62 - $32.54 $1.91 Million - $2.75 Million	84,618 Added 576.57%	99,294 $2.3 Million
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $526,766 - $908,257	-23,023 Reduced 61.07%	14,676 $370,000
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $753,905 - $1.03 Million	-23,790 Reduced 38.69%	37,699 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $26,505 - $39,607	-753 Reduced 1.21%	61,489 $2.42 Million
Q3 2021 Nov 09, 2021	BUY	$46.35 - $59.75 $802,921 - $1.04 Million	17,323 Added 38.56%	62,242 $3.04 Million
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $2.16 Million - $3.11 Million	-45,834 Reduced 50.5%	44,919 $2.36 Million
Q1 2021 May 13, 2021	BUY	$30.93 - $59.48 $582,257 - $1.12 Million	18,825 Added 26.17%	90,753 $5.04 Million
Q4 2020 Feb 11, 2021	SELL	$18.53 - $31.5 $694,448 - $1.18 Million	-37,477 Reduced 34.26%	71,928 $2.22 Million
Q3 2020 Nov 12, 2020	BUY	$14.68 - $19.12 $1.15 Million - $1.5 Million	78,455 Added 253.49%	109,405 $2.03 Million
Q2 2020 Aug 12, 2020	BUY	$8.5 - $15.82 $103,147 - $191,975	12,135 Added 64.5%	30,950 $427,000
Q1 2020 May 13, 2020	SELL	$7.25 - $19.22 $203,572 - $539,678	-28,079 Reduced 59.88%	18,815 $172,000
Q4 2019 Feb 10, 2020	BUY	$13.77 - $19.2 $326,555 - $455,328	23,715 Added 102.31%	46,894 $817,000
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $355,110 - $471,656	-23,785 Reduced 50.65%	23,179 $351,000
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $19,227 - $24,198	1,281 Added 2.8%	46,964 $888,000
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $717,593 - $897,102	44,214 Added 3009.8%	45,683 $800,000
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $178,631 - $305,845	-16,586 Reduced 91.86%	1,469 $26,000
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $33,824 - $55,011	-3,717 Reduced 17.07%	18,055 $255,000
Q2 2018 Aug 14, 2018	SELL	$9.6 - $14.6 $497,644 - $756,834	-51,838 Reduced 70.42%	21,772 $211,000
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $139,758 - $301,583	24,519 Added 49.95%	73,610 $733,000
Q4 2017 Feb 14, 2018	BUY	$3.65 - $5.98 $161,556 - $264,686	44,262 Added 916.59%	49,091 $268,000
Q3 2017 Nov 14, 2017	BUY	$3.0 - $6.0 $14,487 - $28,974	4,829	4,829 $29,000

Others Institutions Holding VCEL

# of Institutions

293

Shares Held

50.7M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.24B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account